TFCP2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.31890000032442E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.84408999999164E-05 |
Normal-vs-Stage2 |
6.21869999999358E-05 |
Normal-vs-Stage3 |
3.64799968011198E-10 |
Normal-vs-Stage4 |
6.75220002133159E-09 |
Stage1-vs-Stage2 |
2.715600E-01 |
Stage1-vs-Stage3 |
6.351900E-04 |
Stage1-vs-Stage4 |
8.377500E-04 |
Stage2-vs-Stage3 |
1.579580E-01 |
Stage2-vs-Stage4 |
1.559570E-01 |
Stage3-vs-Stage4 |
9.390000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
9.69919999871394E-09 |
Normal-vs-AfricanAmerican |
8.1408000000005E-05 |
Normal-vs-Asian |
2.024000E-01 |
Caucasian-vs-AfricanAmerican |
7.574400E-01 |
Caucasian-vs-Asian |
4.208200E-01 |
AfricanAmerican-vs-Asian |
4.433800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
8.02559996238017E-09 |
Normal-vs-Female |
1.65249999994899E-06 |
Male-vs-Female |
1.983160E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.27550000000609E-05 |
Normal-vs-Age(41-60Yrs) |
3.28969999996431E-06 |
Normal-vs-Age(61-80Yrs) |
1.44820000436141E-08 |
Normal-vs-Age(81-100Yrs) |
2.0429000002764E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.659180E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.863800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.856600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.940980E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.377610E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.314400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
7.546400E-01 |
Normal-vs-Grade 2 |
1.98946999999672E-05 |
Normal-vs-Grade 3 |
1.74570002897667E-09 |
Normal-vs-Grade 4 |
1.92759996853198E-09 |
Grade 1-vs-Grade 2 |
7.205800E-02 |
Grade 1-vs-Grade 3 |
7.817400E-03 |
Grade 1-vs-Grade 4 |
2.495600E-03 |
Grade 2-vs-Grade 3 |
7.018700E-03 |
Grade 2-vs-Grade 4 |
8.788400E-04 |
Grade 3-vs-Grade 4 |
1.775210E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.00099999999592E-05 |
Normal-vs-ccB subtype |
2.14179999957764E-07 |
ccA subtype-vs-ccB subtype |
4.217900E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
9.44310000194903E-08 |
Normal-vs-N1 |
2.943900E-02 |
N0-vs-N1 |
6.495400E-01 |
|
|